ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.743,58
-0,45%
S&P 500
5.753,27
1,51%
US Dollar vs BRL
5,73056
-0,07%
Bitcoin
88.074,49
2,34%
Brent Oil
72,525
0,95%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) Notícias

CELC

Celcuity (CELC)

Celcuity Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CELC
DataHoraFonteTítuloCódigoCompanhia
24/03/202508:05GlobeNewswire Inc.Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call NASDAQ:CELCCelcuity Inc
27/02/202512:10PR Newswire (US)Oncology Breakthroughs: How Cancer Research Is Advancing in 2025NASDAQ:CELCCelcuity Inc
25/02/202509:05GlobeNewswire Inc.Celcuity to Participate at Upcoming Cowen and Leerink Investor ConferencesNASDAQ:CELCCelcuity Inc
18/02/202518:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
14/02/202519:14Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CELCCelcuity Inc
11/12/202409:05GlobeNewswire Inc.Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer SymposiumNASDAQ:CELCCelcuity Inc
06/12/202418:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELCCelcuity Inc
06/12/202418:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CELCCelcuity Inc
03/12/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CELCCelcuity Inc
26/11/202418:06Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CELCCelcuity Inc
14/11/202419:46Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CELCCelcuity Inc
14/11/202419:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELCCelcuity Inc
14/11/202418:01GlobeNewswire Inc.Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:CELCCelcuity Inc
12/11/202409:05GlobeNewswire Inc.Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor ConferencesNASDAQ:CELCCelcuity Inc
07/11/202409:05GlobeNewswire Inc.Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference CallNASDAQ:CELCCelcuity Inc
15/10/202410:55Edgar (US Regulatory)Form D/A - Notice of Exempt Offering of Securities: [Amend]NASDAQ:CELCCelcuity Inc
30/08/202417:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CELCCelcuity Inc
28/08/202417:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CELCCelcuity Inc
28/08/202417:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELCCelcuity Inc
26/08/202418:41Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CELCCelcuity Inc
23/08/202411:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CELCCelcuity Inc
16/08/202418:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CELCCelcuity Inc
14/08/202417:01GlobeNewswire Inc.Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:CELCCelcuity Inc
07/08/202408:05GlobeNewswire Inc.Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference CallNASDAQ:CELCCelcuity Inc
03/06/202417:01GlobeNewswire Inc.Celcuity To Participate in Jefferies Global Healthcare ConferenceNASDAQ:CELCCelcuity Inc
30/05/202408:36GlobeNewswire Inc.Celcuity Announces Pricing of Underwritten Common Stock OfferingNASDAQ:CELCCelcuity Inc
30/05/202408:00GlobeNewswire Inc.Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt FinancingNASDAQ:CELCCelcuity Inc
20/05/202418:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CELCCelcuity Inc
15/05/202417:01GlobeNewswire Inc.Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CELCCelcuity Inc
08/05/202408:05GlobeNewswire Inc.Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference CallNASDAQ:CELCCelcuity Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CELC

Seu Histórico Recente

EU
ATAWG
AEX All Tradable Alterna...
DGFX
BSTBTC
BlockStamp
COIN
RUNEEEEBTC
Rune
LATK
PAXGUSDT
Paxos Gold
EU
AEX4L
AEX X4 everage Net Return
Delayed Upgrade Clock
ADVFN Logo
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios